(lp0
S'Assembly Biosciences Inc. ASMB  Wall Street Journal - Mar 12, 2011 Assembly Biosciences Inc. ASMB . search. View All companies. AT CLOSE 4:00 PM EST 03/10/17. $23.33 USD; 0.77 3.41%.'
p1
aS'Ventrus Biosciences Becomes Assembly Biosciences as Stockholders Approve ... GlobeNewswire  - Jul 14, 2014 NEW YORK, July 14, 2014  -- Ventrus Biosciences, Inc.  today announced that its stockholders have approved the issuance of common stock in connection with the merger between Ventrus and Assembly Pharmaceuticals&nbsp;...Ventrus Merges with Assembly Pharmaceuticals, Changes Name - Genetic Engineering News'
p2
aS'Assembly Biosciences Announces Senior Management Changes GlobeNewswire  - Feb 17, 2015 NEW YORK, Feb. 17, 2015  -- Assembly Biosciences, Inc.  today announced a number of senior management changes.'
p3
aS'Assembly Biosciences Expands Senior Leadership Team GlobeNewswire  - Jan 11, 2016 INDIANAPOLIS, Jan. 11, 2016  -- Assembly Biosciences, Inc. , a biotechnology company developing curative treatments for infectious diseases including hepatitis B virus  and C. difficile  infections, today&nbsp;...'
p4
aS'Shares of Assembly Biosciences, Inc.  Sees Large Outflow of Money Energy Index - Mar 14, 2017 Assembly Biosciences, Inc.  During the most recent session, the shares traded at 3.35 points or 14.36% higher at $26.68.'
p5
aS"Assembly Biosciences Reaches The Clinic Seeking Alpha - Nov 16, 2016 The company's lead product candidate is a potential curative treatment for hepatitis B virus . Although ABI-H0731 is behind in development compared to some others, those ahead may provide a blueprint for action."
p6
aS'Assembly Biosciences Inc  Jumps 25.12% For the Week Business Review - Mar 15, 2017 Pushing higher over the last five sessions are shares of Assembly Biosciences Inc . The stock has risen 25.12% over that span, yielding profits for savvy traders.'
p7
aS'Assembly Biosciences Deal Worth at Least $50M Inside INdiana Business - Jan 11, 2017 An international pharmaceutical company has reached an agreement with Assembly Biosciences Inc.  in Carmel involving several compounds to treat gastrointestinal problems.'
p8
aS"Assembly Biosciences  Reaches $25.24 52-Week High, Barrow Hanley ... HuronReport - Mar 13, 2017 The stock of Assembly Biosciences Inc  hit a new 52-week high and has $27.26 target or 8.00% above today's $25.24 share price."
p9
aS'Assembly Biosciences Reports Successful Clinical Study on Gemicel Pharmaceutical Technology Magazine   - Dec 9, 2015 On Dec. 9, 2015, Assembly Biosciences, Inc., a biotechnology company focused on developing treatments for hepatitis B virus and Clostridium difficile infections , reported a successful clinical study validating the utility of the oral Gemicel ...'
p10
a.